At Tidal, we are engaged in offering innovative formulations that offer sustained value to all our customers.

This entails continuous scaling up in the areas of technology, products and commercial operations. We believe that alliancing and partnering can help in optimizing organization synergies and build inorganic growth opportunities.

Increased acceptance of generics and favorable legislation, together with the large volume of branded products losing patent protection over the coming years, have led to continued expansion of the global generic pharmaceuticals market.

Tidal is uniquely placed to capitalize on this opportunity by leveraging its product development capabilities, state of the art manufacturing capacities and access to its low cost skilled manpower, which offers potential partners significant supply chain efficiencies.
  Integrated pharmaceutical company
  Best in class GMP Compliant Manufacturing Facilities
  Pan India Sales Force
  Robust Distribution Network
  In-licensing innovative products
  Global Alliances for Formulations
  Alliances for CRAMS